Bio-adhesive vaginal foam Foamix Ltd http://www.levardenafil.com . Offers announced that the business has been chosen to provide at the 34th Annual Conference of the Controlled Launch Culture. A poster entitled Bio-adhesive Vaginal Foam: In-Vitro and In-Vivo Adhesion Profile will be offered by Foamix’s CTO, Dr. Doron Friedman, at the 34th Annual Getting together with of the Controlled Discharge Culture in Long Seaside, California, July 7-11 US, 2007. The abstract will be published in CRS Journal also. Foamix accomplished its goal to end up being the first ever to develop a new kind of vaginal foam automobile.
Within two years, these attributes have been validated in seven in vivo and ex vivo versions preclinically, highlighting the efficiency of the technology. The incredible diversity of antibodies produced from our platform we can preferentially go for leads with just the highest quality practical properties. Yasunori Yamaguchi, CEO and President of BioWa, commented additional: ‘We are very happy to have this set up with a forward thinking company such as for example arGEN-X.’.